The Science of Cancer Health Equity for Sexual and Gender Minority Communities
性和性别少数群体的癌症健康公平科学
基本信息
- 批准号:10749970
- 负责人:
- 金额:$ 3.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-22 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAmerican Cancer SocietyAreaAttentionAwardAwarenessBackCancer CenterCancer ControlCancer PatientCancer ScienceCancer SurvivorshipCancer health equityCaregiversCollaborationsCommunitiesCommunity ActionsComplexConsensusDataData CollectionDiagnosisDisparityEpidemiologyFeesFundingFutureGender IdentityGeographyHealthIndividualInfrastructureInterventionLesbian Gay Bisexual TransgenderLesbian Gay Bisexual Transgender IntersexLevel of EvidenceLos AngelesMalignant NeoplasmsMedical centerMentorshipMinorityModelingModificationNamesNational Cancer InstituteNational Institute on Minority Health and Health DisparitiesNew YorkNew York CityParticipantPatientsPeer ReviewPersonsPoliciesPopulationPopulations at RiskProfessional OrganizationsPublicationsRecording of previous eventsResearchResearch MethodologyResearch PersonnelResearch PriorityRisk FactorsSafetyScienceScientistScreening for cancerSex OrientationSexual and Gender MinoritiesStructureSurvivorsTechniquesTrainingTravelUnited States National Institutes of HealthUniversitiesWorkanticancer researchcancer diagnosiscancer health disparitycancer preventioncancer riskcommunity engagementcommunity organizationscostdisparity reductionexperiencegender minority communitygender minority groupinnovationinterestintersectionalitylifetime riskmeetingsmemberminority stressnovelnovel strategiesposterssocialsymposiumtransgender
项目摘要
ABSTRACT
Sexual and gender minority people (SGM) experience multiple cancer-related disparities, including higher rates
of cancer risk factors, lower rates of cancer screening, higher lifetime risk of cancer, and unmet needs during
cancer survivorship. Although many national organizations, including the National Cancer Institute (NCI) and the
American Cancer Society (ACS), have stated the need for more cancer research among SGM communities,
there is currently no consensus about the highest research priorities, promising research models, or mechanisms
for collaboration between geographically dispersed scientific teams. To address this gap, we propose a two-and-
a-half day conference focused on the “Science of Cancer Health Equity for SGM Communities.” This
conference will bring together researchers, trainees, early-stage investigators, and community stakeholders to
review the current science on cancer health equity for SGM persons, identify high-priority research topics, and
develop novel approaches to engage communities and influence policy. The conference will be held at the New
York University (NYU) Langone Medical Center Campus in New York City from October 5-7, 2023. It is structured
around a transdisciplinary framework: looking within, across, and between areas of scientific expertise and
community wisdom to establish priorities. In line with this framework, we have convened a conference organizing
committee comprising two MPIs, representatives from 7 cancer centers, and a SGM Community Action Board,
with strong support from SGM community organizations such as the National LGBT Cancer Network.
Support from the NCI R13 mechanism (PA-21-151) is needed to cover speaker fees as well as travel costs
for trainees, early-stage investigators, patients and community participants. The aims of this conference
are: 1) to examine the current level of evidence informing research across the cancer control continuum for
SGM cancer patients, survivors, and caregivers; 2) to establish future research priorities across the cancer
control continuum for SGM cancer patients, survivors, and caregivers; 3) to promote the research of trainees
and early stage investigators, especially those from minoritized backgrounds, interested in research across
the cancer control continuum for SGM communities; 4) to develop a transdisciplinary network of scholars
with a focus on mentorship and on shared research methods that can address cancer health equity across the
cancer control continuum; 5) to disseminate findings from this conference, including priorities for future SGM
cancer health equity research, through a publicly available executive summary and a peer-reviewed, open
access publication. If funded, this conference will produce: (a) a publicized list of SGM cancer health equity
research priorities and (b) a network of transdisciplinary researchers and community members ready to
collaborate on projects addressing these priorities. This R13 award will also help us create an infrastructure
for future conferences to continue this work, with the next hosted by Cedars Sinai in Los Angeles in 2024.
抽象的
性别和性别少数群体 (SGM) 经历多种与癌症相关的差异,包括较高的发病率
癌症风险因素、较低的癌症筛查率、较高的终生癌症风险以及未满足的需求
尽管许多国家组织,包括国家癌症研究所 (NCI) 和
美国癌症协会 (ACS) 表示 SGM 社区需要进行更多癌症研究,
目前对于最高研究优先事项、有前途的研究模式或机制尚未达成共识
为了解决地理上分散的科学团队之间的合作,我们提出了一个“二并”的方案。
为期半天的会议重点讨论“SGM 社区的癌症健康公平科学”。
会议将汇集研究人员、实习生、早期研究人员和社区利益相关者
回顾 SGM 人员癌症健康公平性的最新科学,确定高度优先的研究主题,以及
制定新的方法来吸引社区并影响政策 会议将在新大楼举行。
约克大学 (NYU) 朗格医学中心校区于 2023 年 10 月 5 日至 7 日在纽约市举行。
围绕跨学科框架:在科学专业知识领域内、跨领域和之间进行研究
根据这一框架,我们召开了一次组织会议,集思广益,确定优先事项。
委员会由两个MPI、来自7个癌症中心的代表和一个SGM社区行动委员会组成,
得到全国LGBT癌症网络等SGM社区组织的大力支持。
需要 NCI R13 机制 (PA-21-151) 的支持来支付演讲者费用以及差旅费
针对学员、早期研究人员、患者和社区参与者 本次会议的目的。
是:1)检查当前的证据水平,为整个癌症控制连续体的研究提供信息
SGM 癌症患者、幸存者和护理人员;2) 确定未来的癌症研究重点;
SGM 癌症患者、幸存者和护理人员的控制连续体 3) 促进学员的研究;
和早期研究人员,特别是那些来自少数族裔背景、对跨领域研究感兴趣的人
SGM 社区的癌症控制连续体;4) 建立跨学科的学者网络;
重点是指导和共享研究方法,可以解决整个癌症健康公平问题
5) 传播本次会议的研究结果,包括未来 SGM 的优先事项
癌症健康研究公平性,通过公开的执行摘要和同行评审的开放
如果获得资助,本次会议将产生: (a) SGM 癌症健康公平的公开清单。
研究重点以及 (b) 一个由跨学科研究人员和社区成员组成的网络,准备好
合作解决这些优先事项的项目也将帮助我们创建基础设施。
未来的会议将继续开展这项工作,下一次会议将于 2024 年在洛杉矶由 Cedars Sinai 主办。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Charles Stewart Kamen其他文献
Charles Stewart Kamen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Charles Stewart Kamen', 18)}}的其他基金
A Multi-Institute Survivorship Study of Patients Living with Advanced Cancer Who Have Had Durable Response to Immune Checkpoint Inhibitors
对免疫检查点抑制剂有持久反应的晚期癌症患者的多机构生存研究
- 批准号:
10714336 - 财政年份:2023
- 资助金额:
$ 3.25万 - 项目类别:
Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 in a Community Oncology Setting
免疫检查点抑制剂治疗 (DiRECT) 结果的差异:在社区肿瘤学环境中接受抗 PD-1/抗 PD-L1 治疗的癌症幸存者的前瞻性队列研究
- 批准号:
10883853 - 财政年份:2021
- 资助金额:
$ 3.25万 - 项目类别:
Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 in a Community Oncology Setting
免疫检查点抑制剂治疗 (DiRECT) 结果的差异:在社区肿瘤学环境中接受抗 PD-1/抗 PD-L1 治疗的癌症幸存者的前瞻性队列研究
- 批准号:
10220449 - 财政年份:2021
- 资助金额:
$ 3.25万 - 项目类别:
Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 in a Community Oncology Setting
免疫检查点抑制剂治疗 (DiRECT) 结果的差异:在社区肿瘤学环境中接受抗 PD-1/抗 PD-L1 治疗的癌症幸存者的前瞻性队列研究
- 批准号:
10391553 - 财政年份:2021
- 资助金额:
$ 3.25万 - 项目类别:
Exercise Intervention for Lesbian, Gay, Bisexual, and Transgender Cancer Survivors
针对女同性恋、男同性恋、双性恋和变性癌症幸存者的运动干预
- 批准号:
9112953 - 财政年份:2015
- 资助金额:
$ 3.25万 - 项目类别:
Exercise Intervention for Lesbian, Gay, Bisexual, and Transgender Cancer Survivors
针对女同性恋、男同性恋、双性恋和变性癌症幸存者的运动干预
- 批准号:
9512855 - 财政年份:2015
- 资助金额:
$ 3.25万 - 项目类别:
相似海外基金
Fertility experiences among ethnically diverse adolescent and young adult cancer survivors: A population-based study
不同种族青少年和年轻成年癌症幸存者的生育经历:一项基于人群的研究
- 批准号:
10744412 - 财政年份:2023
- 资助金额:
$ 3.25万 - 项目类别:
University of Florida Health Cancer Center Support Grant
佛罗里达大学健康癌症中心支持补助金
- 批准号:
10625750 - 财政年份:2023
- 资助金额:
$ 3.25万 - 项目类别:
Health equity in fertility specialty care among cancer survivors
癌症幸存者生育专科护理的健康公平
- 批准号:
10561780 - 财政年份:2023
- 资助金额:
$ 3.25万 - 项目类别: